Product profile

Cardiogen

$90.00

Overview

A tetrapeptide cytoprotective compound researched for its role in cardiomyocyte gene regulation, cardiac tissue homeostasis, and myocardial cellular defense mechanisms.

Concentration
20 mg
Stock
In stock

Product details

Cardiogen is a synthetic tetrapeptide (Alanine-Glutamate-Aspartate-Arginine) developed from cardiac tissue proteins and investigated for its capacity to modulate gene expression within cardiomyocytes. It represents a model bioregulatory peptide for studying intrinsic cardiac repair signaling and myocardial cytoprotection under stress conditions.

  • Receptor Targets: Nuclear chromatin interactions, cardiomyocyte transcription factor pathways, mitochondrial protective signaling
  • Key Feature: Cardiac-specific bioregulatory tetrapeptide with gene expression modulatory activity
  • Research Focus Areas: Myocardial cytoprotection, cardiomyocyte homeostasis, cardiac gene regulation, ischemic injury response
  • Common Models: Myocardial ischemia-reperfusion models, cardiomyocyte stress assays, cardiac aging paradigms, oxidative cardiac injury studies
  • Mechanistic Interests: Cardiomyocyte gene transcription modulation, mitochondrial integrity support, anti-apoptotic signaling, cardiac tissue repair induction

It is used in research to explore myocardial gene regulatory networks, cardiac cytoprotective mechanisms, and cellular resilience under ischemic or oxidative stress conditions.

All products currently listed on this site are for research purposes only.

cardiogen vial